Filing Details
- Accession Number:
- 0001140361-15-024344
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-15 18:41:54
- Reporting Period:
- 2015-06-11
- Filing Date:
- 2015-06-15
- Accepted Time:
- 2015-06-15 18:41:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1416792 | Relypsa Inc | RLYP | Pharmaceutical Preparations (2834) | 260893742 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1309702 | J Paul Hastings | C/O Relypsa, Inc. 100 Cardinal Way Redwood City CA 94063 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-06-11 | 1,454 | $34.63 | 3,508 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- Represents shares sold to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") and delivery of shares.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.18 to $35.14, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Includes 2,250 RSUs.
Billionaire Hedge Funds
